Cargando…
NKp44L: A new tool for fighting cancer
We have recently identified that the ligand of natural cytotoxicity triggering receptor 2 (NCR2, best known as NKp44) is expressed on a large panel of malignant cells. This ligand provides a new tool to investigate how stressed cells are recognized and eliminated by natural killer (NK) cells, and to...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008457/ https://www.ncbi.nlm.nih.gov/pubmed/24800176 http://dx.doi.org/10.4161/onci.27988 |
_version_ | 1782314453572780032 |
---|---|
author | Vieillard, Vincent Baychelier, Florence Debré, Patrice |
author_facet | Vieillard, Vincent Baychelier, Florence Debré, Patrice |
author_sort | Vieillard, Vincent |
collection | PubMed |
description | We have recently identified that the ligand of natural cytotoxicity triggering receptor 2 (NCR2, best known as NKp44) is expressed on a large panel of malignant cells. This ligand provides a new tool to investigate how stressed cells are recognized and eliminated by natural killer (NK) cells, and to develop novel immunotherapeutic paradigms against cancer. |
format | Online Article Text |
id | pubmed-4008457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-40084572015-02-14 NKp44L: A new tool for fighting cancer Vieillard, Vincent Baychelier, Florence Debré, Patrice Oncoimmunology Author's View We have recently identified that the ligand of natural cytotoxicity triggering receptor 2 (NCR2, best known as NKp44) is expressed on a large panel of malignant cells. This ligand provides a new tool to investigate how stressed cells are recognized and eliminated by natural killer (NK) cells, and to develop novel immunotherapeutic paradigms against cancer. Landes Bioscience 2014-02-14 /pmc/articles/PMC4008457/ /pubmed/24800176 http://dx.doi.org/10.4161/onci.27988 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Author's View Vieillard, Vincent Baychelier, Florence Debré, Patrice NKp44L: A new tool for fighting cancer |
title | NKp44L: A new tool for fighting cancer |
title_full | NKp44L: A new tool for fighting cancer |
title_fullStr | NKp44L: A new tool for fighting cancer |
title_full_unstemmed | NKp44L: A new tool for fighting cancer |
title_short | NKp44L: A new tool for fighting cancer |
title_sort | nkp44l: a new tool for fighting cancer |
topic | Author's View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008457/ https://www.ncbi.nlm.nih.gov/pubmed/24800176 http://dx.doi.org/10.4161/onci.27988 |
work_keys_str_mv | AT vieillardvincent nkp44lanewtoolforfightingcancer AT baychelierflorence nkp44lanewtoolforfightingcancer AT debrepatrice nkp44lanewtoolforfightingcancer |